GC Biopharma acquires ABO Holding for $96 mn
South Korea’s GC Biopharma Corp. said on Thursday it acquired the US-based medical-grade source blood plasma company ABO Holding Inc. The...
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Hyundai Motor releases 2025 Santa Fe
Hyundai Motor Co. said on Tuesday that it released the 2025 Santa Fe, a model year change of its flagship midsize sports utility vehicle (SUV) The A...
GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn
South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...
GC Biopharma exports Alyglo to US
South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglob...
Eugene PE, KDB PE to acquire Boryung Biopharma for $231 million
A consortium of Eugene Private Equity and Korea Development Bank Private Equity will acquire 80% of South Korean vaccine maker Boryung Biopharma Co....
OCI eyes acquisition of US biopharmaceutical company
OCI Holdings Co., South Korea’s largest polysilicon maker, is looking abroad to acquire a biopharmaceutical company in the US in a consortium,...
Korea’s Celltrion, SK Biopharmaceuticals benefit from direct US sales
Celltrion Inc. and SK Biopharmaceuticals Co. are witnessing improving sales revenue and profitability by selling their products through their own ma...
GC Biopharma aims to boost Alyglo sales sixfold in the US
CHEONGJU, North Chungcheong Province -- South Korea’s major pharmaceutical company GC Biopharma Corp. aims to raise the sales of Alyglo, its i...
Biopharma M&As: Next big thing for South Korean manufacturers
When Orion Corp., known for its signature snack cake Choco-Pie, announced a $415 million deal to acquire biotech startup LegoChem Biosciences Inc. l...
GC Biopharma gets FDA approval for Alyglo
South Korea’s GC Biopharma Corp. announced on Monday that it received approval from the US Food and Drug Administration (FDA) for the immuno...
GC Biopharma breaks ground on blood product plant in Indonesia
South Korea’s GC Biopharma Corp. broke ground on Wednesday on Indonesia’s first blood product plant through technology transfer.Indonesi...
Hanwha to re-enter biopharma market, targeting biomaterials
South Korea’s Hanwha Group will re-enter the biopharmaceutical market to become the country’s sole producer of tris buffers, a key reage...
GC Biopharma wins $10 mn order for flu vaccine in Thailand
South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...
SK Biopharma’s Cenobamate US patent extended by 2032
South Korea's SK Biopharmaceuticals announced on Friday an extension of its US patent for the epilepsy treatment Cenobamate, now set to expire on Oc...
Prestige Biologics partners with Indian company for CDMO
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...
EuBiologics, GC Biopharma to jointly produce cholera vaccine
South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...
GC Biopharma wins approval for quadrivalent flu vaccine in Egypt
South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...
Prestige Biopharma participates in US gov’t Cancer Moonshot
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, announced on Tuesday that it will partici...
GC Biopharma inks $90mn deal for blood products in Brazil
South Korea's GC Biopharma Corp. on Monday announced on Monday that it has a supply contract with Blau Farmacêutica, a Brazilian pharmaceutica...
GC Biopharma wins contract to build blood products plant in Indonesia
GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Healt...
CrystalGenomics to sell largest 20% stake to Invites Healthcare for $44 mn
CrystalGenomics Inc., South Korea’s first-generation biopharma venture company, will sell new shares worth 58 billion won ($44 million) in a b...
Merck to build biopharma raw material plant in Korea
Global pharmaceutical company Merck is considering a plan to establish a biopharmaceutical raw material production facility in Daejeon.South Korean ...
Dongwon backs out of Boryung Biopharma buyout deal
Dongwon Industries Co., South Korea’s No. 1 canned tuna producer, has backed out of a deal estimated between $400 million and $500 million to ...
GC Biopharma wins $44 mn flu vaccine order from WHO agency
South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a d...
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
S.Korea's Prestige Biologics attracts $59 mn overseas investment
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Tuesday th...
GC Biopharma's licensed flu vaccine gets approval in Taiwan
South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the ...
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
GC Biopharma introduces candidates for treating blood coagulation disease
South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...
